AbbVie Inc. (ABBV)
Drug Manufacturers - General · Healthcare · $384.1B
Intrinsic Value (Consensus)
$39.55
Current Price
$216.53
Margin of Safety
-81.7%
81.7% Above Intrinsic Value
Value: $40
Price: $217
High-growth stock: AbbVie Inc. trades at 95x earnings. Our models use trailing earnings and may undervalue companies with strong future growth potential. The market may be pricing in growth that traditional valuation models don't fully capture.
Valuation Model Estimates
Current Price: $216.53
DCF (Discounted Cash Flow)
$39.00
Graham Number
Not applicable
—
Earnings Power Value
$28.07
Relative Value (P/E)
$40.98
Dividend Discount Model
$50.14
Consensus Value
$39.55
Model Assumptions
Discount Rate
10.3%
Growth Rate
3.9%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
38
Profitability
10/25
Strength
18/25
Valuation
0/25
Growth
10/25
Financial Health Signals
High P/E ratio (95) — priced for significant growth
Key Financials
- EPS (TTM)
- $2.05
- EPS (Forward)
- $2.13
- Book Value
- $-1.84
- P/E Ratio
- 95.2
- Forward P/E
- 93.3
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 8.6%
- Earnings Growth
- 3.9%
- Dividend Yield
- 0.8%
- Beta
- 0.27
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance